Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen H Reaney

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Toxicological Sciences : an Official Journal of the Society of Toxicology|June 3, 2006
Brain accumulation and toxicity of Mn(II) and Mn(III) exposuresStephen H Reaney, Graham Bench, Donald R Smith
Chemical Research in Toxicology|September 17, 2002
Manganese oxidation state and its implications for toxicityStephen H Reaney, Catherine L Kwik-Uribe, Donald R Smith
Experimental Neurology|August 22, 2006
Comparison of the neurotoxic effects of proteasomal inhibitors in primary mesencephalic culturesStephen H Reaney, Louisa C Johnston, William J Langston, et al.
Brain Research. Molecular Brain Research|March 26, 2005
Redox cycling of the herbicide paraquat in microglial culturesDafna Bonneh-Barkay, Stephen H Reaney, William J Langston, et al.
The Journal of Biological Chemistry|December 26, 2006
Effect of 4-hydroxy-2-nonenal modification on alpha-synuclein aggregationZhijie Qin, Dongmei Hu, Shubo Han, et al.
Biochimica Et Biophysica Acta|December 23, 2009
Methionine oxidation stabilizes non-toxic oligomers of alpha-synuclein through strengthening the auto-inhibitory intra-molecular long-range interactionsWenbo Zhou, Chunmei Long, Stephen H Reaney, et al.
Annals of Neurology|July 25, 2006
Lack of nigrostriatal pathology in a rat model of proteasome inhibitionAmy B Manning-Boğ, Stephen H Reaney, Vivian P Chou, et al.
Neurobiology of Disease|June 15, 2007
Increased vulnerability of nigrostriatal terminals in DJ-1-deficient mice is mediated by the dopamine transporterAmy B Manning-Boğ, W Michael Caudle, Xiomara A Perez, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Toxicological Sciences : an Official Journal of the Society of Toxicology|June 3, 2006
Brain accumulation and toxicity of Mn(II) and Mn(III) exposuresStephen H Reaney, Graham Bench, Donald R Smith
Chemical Research in Toxicology|September 17, 2002
Manganese oxidation state and its implications for toxicityStephen H Reaney, Catherine L Kwik-Uribe, Donald R Smith
Experimental Neurology|August 22, 2006
Comparison of the neurotoxic effects of proteasomal inhibitors in primary mesencephalic culturesStephen H Reaney, Louisa C Johnston, William J Langston, et al.
Brain Research. Molecular Brain Research|March 26, 2005
Redox cycling of the herbicide paraquat in microglial culturesDafna Bonneh-Barkay, Stephen H Reaney, William J Langston, et al.
The Journal of Biological Chemistry|December 26, 2006
Effect of 4-hydroxy-2-nonenal modification on alpha-synuclein aggregationZhijie Qin, Dongmei Hu, Shubo Han, et al.
Biochimica Et Biophysica Acta|December 23, 2009
Methionine oxidation stabilizes non-toxic oligomers of alpha-synuclein through strengthening the auto-inhibitory intra-molecular long-range interactionsWenbo Zhou, Chunmei Long, Stephen H Reaney, et al.
Annals of Neurology|July 25, 2006
Lack of nigrostriatal pathology in a rat model of proteasome inhibitionAmy B Manning-Boğ, Stephen H Reaney, Vivian P Chou, et al.
Neurobiology of Disease|June 15, 2007
Increased vulnerability of nigrostriatal terminals in DJ-1-deficient mice is mediated by the dopamine transporterAmy B Manning-Boğ, W Michael Caudle, Xiomara A Perez, et al.
Pageof 1